Literature DB >> 20304328

Neuropathology in succinic semialdehyde dehydrogenase deficiency.

Ina Knerr1, K Michael Gibson, Geoffrey Murdoch, Gajja S Salomons, Cornelis Jakobs, Susan Combs, Phillip L Pearl.   

Abstract

Reported here is the novel finding of neuropathology in a patient with succinic semialdehyde dehydrogenase deficiency, an inherited disorder of gamma-aminobutyric acid metabolism characterized by intellectual deficiency, hypotonia, and epilepsy, with 4-hydroxybutyric aciduria and abnormalities of the globus pallidus on neuroimaging. A 19-year-old woman of European origin with a neurodevelopmental disorder and epilepsy died unexpectedly in 1998. A postmortem examination was performed, with a final diagnosis of sudden unexpected death in epilepsy patients. Eight years later, her sister with a neurodevelopmental disorder presented at 13 years of age with seizures and was diagnosed with succinic semialdehyde dehydrogenase deficiency. In the decedent, succinic semialdehyde dehydrogenase deficiency was established at the molecular level, 10 years after her death, using genomic DNA from brain tissue specimens. The neuropathologic findings revealed striking discoloration of the globi pallidi, leptomeningeal congestion, and a scar in the frontal cortex. After detection of the pathogenic homozygous mutation c.1226G>A, p.Gly409Asp in the living sister, it was confirmed in the decedent. An underlying metabolic disease may be an additional risk factor for sudden unexpected death in epilepsy patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304328      PMCID: PMC3155415          DOI: 10.1016/j.pediatrneurol.2009.11.011

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

1.  Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.

Authors:  J E Galvin; B Giasson; H I Hurtig; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  4-Hydroxybutyric aciduria: application of a fluorometric assay to the determination of succinic semialdehyde dehydrogenase activity in extracts of cultured human lymphoblasts.

Authors:  K M Gibson; C F Lee; K L Chambliss; V Kamali; B Francois; J Jaeken; C Jakobs
Journal:  Clin Chim Acta       Date:  1991-02-15       Impact factor: 3.786

3.  Basal Ganglia calcification in mitochondrial disorders.

Authors:  Josef Finsterer; Wolfgang Kopsa
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

4.  Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-/- mice).

Authors:  S W Sauer; S Kölker; G F Hoffmann; H J Ten Brink; C Jakobs; K M Gibson; J G Okun
Journal:  Neurochem Int       Date:  2007-01-13       Impact factor: 3.921

Review 5.  Sudden unexpected death in epilepsy patients: Risk factors. A systematic review.

Authors:  C P J A Monté; J B A M Arends; I Y Tan; A P Aldenkamp; M Limburg; M C T F M de Krom
Journal:  Seizure       Date:  2006-11-28       Impact factor: 3.184

6.  Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).

Authors:  K Michael Gibson; Maneesh Gupta; Phillip L Pearl; Mendel Tuchman; L Gilbert Vezina; O Carter Snead; Leo M E Smit; Cornelis Jakobs
Journal:  Biol Psychiatry       Date:  2003-10-01       Impact factor: 13.382

7.  Sudden unexpected death in epilepsy: terminology and definitions.

Authors:  L Nashef
Journal:  Epilepsia       Date:  1997-11       Impact factor: 5.864

8.  Comparison of heart mass in seizure patients dying of sudden unexplained death in epilepsy to sudden death due to some other cause.

Authors:  Gregory G Davis; Gerald McGwin
Journal:  Am J Forensic Med Pathol       Date:  2004-03       Impact factor: 0.921

9.  Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Authors:  P L Pearl; K M Gibson; M T Acosta; L G Vezina; W H Theodore; M A Rogawski; E J Novotny; A Gropman; J A Conry; G T Berry; M Tuchman
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

10.  Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.

Authors:  Shinjiro Akaboshi; Boris M Hogema; Andrea Novelletto; Patrizia Malaspina; Gajja S Salomons; George D Maropoulos; Cornelis Jakobs; Markus Grompe; K Michael Gibson
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

View more
  11 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

2.  Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Authors:  Phillip L Pearl; Lovy Shukla; William H Theodore; Cornelis Jakobs; K Michael Gibson
Journal:  Brain Dev       Date:  2011-06-12       Impact factor: 1.961

Review 3.  Inherited disorders of gamma-aminobutyric acid metabolism and advances in ALDH5A1 mutation identification.

Authors:  Phillip L Pearl; Mahsa Parviz; Kara Vogel; John Schreiber; William H Theodore; K Michael Gibson
Journal:  Dev Med Child Neurol       Date:  2014-12-29       Impact factor: 5.449

4.  Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.

Authors:  Mahsa Parviz; Kara Vogel; K Michael Gibson; Phillip L Pearl
Journal:  J Pediatr Epilepsy       Date:  2014-11-25

5.  Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  E E Jansen; K R Vogel; G S Salomons; P L Pearl; J-B Roullet; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2016-09-29       Impact factor: 4.982

6.  Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.

Authors:  Samuel Lapalme-Remis; Evan Cole Lewis; Christine De Meulemeester; Pranesh Chakraborty; K Michael Gibson; Carlos Torres; Alan Guberman; Gajja S Salomons; Cornelis Jakobs; Andre Ali-Ridha; Mahsa Parviz; Phillip L Pearl
Journal:  Neurology       Date:  2015-08-12       Impact factor: 9.910

Review 7.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

8.  Metabolic causes of epileptic encephalopathy.

Authors:  Joe Yuezhou Yu; Phillip L Pearl
Journal:  Epilepsy Res Treat       Date:  2013-05-22

9.  OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report.

Authors:  Sachin Phakey; Thomas Rego; Frank Gaillard; Julie Panetta; Andrew Evans; Gerard De Jong; Mark Walterfang
Journal:  BMC Psychiatry       Date:  2020-08-05       Impact factor: 3.630

Review 10.  Succinic Semialdehyde Dehydrogenase Deficiency: An Update.

Authors:  Miroslava Didiášová; Antje Banning; Heiko Brennenstuhl; Sabine Jung-Klawitter; Claudio Cinquemani; Thomas Opladen; Ritva Tikkanen
Journal:  Cells       Date:  2020-02-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.